Evidence map›Paper›PMID 30680314›Full record

ReviewBioengineering & translational medicine2019

Nanocrystals: A perspective on translational research and clinical studies.

Maria Jarvis, Vinu Krishnan, Samir Mitragotri

Abstract readReview
In one paragraph

Review in Bioengineering & translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Curcumin: a potential anti-photoaging agent.Frontiers in pharmacology · 2025
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maria JarvisDept. of Bioengineering Rice University Houston TX 77030.ORCID https://orcid.org/0000-0003-4744-5587
Vinu KrishnanJohn A. Paulson School of Engineering and Applied Sciences Wyss Institute, Harvard University Cambridge MA 02138.
Samir MitragotriJohn A. Paulson School of Engineering and Applied Sciences Wyss Institute, Harvard University Cambridge MA 02138.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Poorly soluble small molecules typically pose translational hurdles owing to their low solubility, low bioavailability, and formulation challenges. Nanocrystallization is a versatile method for salvaging poorly soluble drugs with the added benefit of a carrier-free delivery system. In this review, we provide a comprehensive analysis of nanocrystals with emphasis on their clinical translation. Additionally, the review sheds light on clinically approved nanocrystal drug products as well as those in development.

Indexed as

clinical trialsnanocrystalsnanomedicinenanoparticlesnanotherapeuticstranslational medicine

Identifiers

PMID30680314
PMCPMC6336669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.